RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
1-Year Return 25.98%
This Quarter Return
+22.15%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.76B
AUM Growth
+$164M
Cap. Flow
-$52M
Cap. Flow %
-1.88%
Top 10 Hldgs %
29.44%
Holding
155
New
8
Increased
52
Reduced
20
Closed
10

Top Buys

1
BSX icon
Boston Scientific
BSX
$24.2M
2
ALLK
Allakos
ALLK
$18.2M
3
EHC icon
Encompass Health
EHC
$17.7M
4
ELAN icon
Elanco Animal Health
ELAN
$13.1M
5
ZBH icon
Zimmer Biomet
ZBH
$8.41M

Top Sells

1
ALXN
Alexion Pharmaceuticals Inc
ALXN
$26.8M
2
ABBV icon
AbbVie
ABBV
$26M
3
GILD icon
Gilead Sciences
GILD
$25.9M
4
ACHC icon
Acadia Healthcare
ACHC
$19.5M
5
NUVA
NuVasive, Inc.
NUVA
$19.4M

Sector Composition

1 Healthcare 89.9%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ZGNX
76
DELISTED
Zogenix, Inc.
ZGNX
$11.7M 0.42%
235,000
+9,000
+4% +$446K
A icon
77
Agilent Technologies
A
$36.5B
$11.6M 0.42%
164,100
+400
+0.2% +$28.2K
TVTX icon
78
Travere Therapeutics
TVTX
$1.93B
$11.5M 0.42%
400,000
– –
MRTX
79
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$11.3M 0.41%
240,000
– –
CHRS icon
80
Coherus Oncology, Inc. Common Stock
CHRS
$150M
$11.1M 0.4%
670,000
-20,000
-3% -$330K
ARDX icon
81
Ardelyx
ARDX
$1.57B
$11M 0.4%
2,525,557
– –
QTTB icon
82
Q32 Bio
QTTB
$20.4M
$10.7M 0.39%
26,111
– –
EXEL icon
83
Exelixis
EXEL
$10.2B
$10.5M 0.38%
595,000
– –
ADAP
84
Adaptimmune Therapeutics
ADAP
$10.9M
$10.2M 0.37%
750,000
– –
TBIO
85
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$10.1M 0.37%
1,009,179
-1,900
-0.2% -$19K
MRSN icon
86
Mersana Therapeutics
MRSN
$34M
$10M 0.36%
40,000
– –
BHVN
87
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$9.76M 0.35%
260,000
-137,500
-35% -$5.16M
MYOV
88
DELISTED
Myovant Sciences Ltd.
MYOV
$9.23M 0.33%
347,500
+52,400
+18% +$1.39M
APTX
89
DELISTED
Aptinyx Inc. Common Stock
APTX
$8.83M 0.32%
305,000
-35,000
-10% -$1.01M
ACHN
90
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$8.83M 0.32%
2,400,000
+50,000
+2% +$184K
SRGA
91
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$8.78M 0.32%
65,000
– –
PTLA
92
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$8.62M 0.31%
323,800
– –
ODT
93
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$8.45M 0.31%
435,500
+37,750
+9% +$733K
FPRX
94
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$8.32M 0.3%
598,000
+5,000
+0.8% +$69.6K
CLVS
95
DELISTED
Clovis Oncology, Inc.
CLVS
$7.96M 0.29%
271,100
+16,100
+6% +$473K
ENTA icon
96
Enanta Pharmaceuticals
ENTA
$189M
$7.91M 0.29%
+92,500
New +$7.91M
BLUE
97
DELISTED
bluebird bio
BLUE
$7.67M 0.28%
4,053
+579
+17% +$1.1M
KURA icon
98
Kura Oncology
KURA
$713M
$7.09M 0.26%
405,000
+5,000
+1% +$87.5K
SAGE
99
DELISTED
Sage Therapeutics
SAGE
$6.92M 0.25%
49,000
– –
ZLAB icon
100
Zai Lab
ZLAB
$3.42B
$6.82M 0.25%
350,000
+50,000
+17% +$974K
2 3
4
5 6